Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage FcγRI, FcγRIII, and FcγRIV

Despite the demonstrated clinical efficacy of CD20 monoclonal antibody (mAb) for lymphoma therapy, the in vivo mechanisms of tumor depletion remain controversial and variable. To identify the molecular mechanisms responsible for lymphoma killing by CD20 mAb in a homologous system amenable to mechani...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Minard-Colin, Veronique, Xiu, Yan, Poe, Jonathan C., Horikawa, Mayuka, Magro, Cynthia M., Hamaguchi, Yasuhito, Haas, Karen M., Tedder, Thomas F.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2008
Soggetti:
Immunobiology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2515149/
https://ncbi.nlm.nih.gov/pubmed/18495955
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-01-135160
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi